ERBB2 and cancer: Since 10 nM 17β-estradiol treatment only partially reproduced the resveratrol effect in CAM6 cells, inducing reduction of ERɑ without enhancing HER2 protein levels, we suppose that resveratrol exerts a more complex action on Δ16HER2+ cancer cells than the mere estrogen-like effect.